Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19)
Clinical trial NCT04742738 · COMPLETED
Trial details
- NCT number
- NCT04742738
- Sponsor
- SK Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-20
- Primary completion
- 2021-07-30
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.